Table 2.
N (%) | |
---|---|
Sexa | |
Male | 497 (41.11%) |
Female | 712 (58.89%) |
Ageb | |
18‐34 | 140 (12.03%) |
35‐64 | 570 (48.97%) |
≥65 | 454 (39.00%) |
Ethnicityc | |
White | 1082 (91.15%) |
Other ethnic group | 105 (8.85%) |
Educational level | |
Degree, degree equivalent and above | 411 (35.16%) |
Other qualifications | 532 (45.51%) |
No qualifications | 226 (19.33%) |
Health status | |
Very good/good | 892 (73.54%) |
Fair/bad/very bad | 321 (26.46%) |
Number of long‐term conditions | |
0 | 330 (27.99%) |
1 | 329 (27.91%) |
2‐3 | 366 (31.04%) |
>3 | 154 (13.06%) |
Number of medications taken | |
0 | 344 (30.10%) |
1‐2 | 311 (27.21%) |
3‐4 | 222 (19.42%) |
>4 | 266 (23.27%) |
Mean (SD) proportion of female registered in the 45 practices that participated in the study: 0.51 (0.05).
Mean (SD) proportion of eligible patients aged >65 registered in the 45 practices that participated in the study: 0.20 (0.01).
Mean (SD) proportion of patients from non‐white ethnicity registered in the 45 practices that participated in the study: 0.18 (0.04).